99% Savings - Buy Urjas Massage Oil Just @1 Rs
Cepo CV 200 Mg/125 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Cepo CV 200 Mg/125 Mg Tablet have also been mentioned below.
The correct dosage of Cepo CV 200 Mg/125 Mg Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Cepo CV 200 Mg/125 Mg Tablet can also lead to other problems, which have been listed below. Such side effects of Cepo CV 200 Mg/125 Mg Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Cepo CV 200 Mg/125 Mg Tablet has a Mild effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Cepo CV 200 Mg/125 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Jaundice must refrain from the use of Cepo CV 200 Mg/125 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Cepo CV 200 Mg/125 Mg Tablet are listed in the contraindications section below.
Drug interactions for Cepo CV 200 Mg/125 Mg Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Cepo CV 200 Mg/125 Mg Tablet is safe while driving, and is is addictive in nature.
Cepo CV 200 Mg/125 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Cepo CV 200 Mg/125 Mg Tablet safe for pregnant women?
Cepo CV has little to no side effects in pregnant women.
Is the use of Cepo CV 200 Mg/125 Mg Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Cepo CV. If you see any side effects, stop taking Cepo CV immediately and talk to your doctor. Take Cepo CV again, only after your doctor's advice.
What is the effect of Cepo CV 200 Mg/125 Mg Tablet on the Kidneys?
Cepo CV may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Cepo CV 200 Mg/125 Mg Tablet on the Liver?
Cepo CV can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Cepo CV 200 Mg/125 Mg Tablet on the Heart?
Cepo CV is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Cepo CV 200 Mg/125 Mg Tablet unless your doctor advises you to do so -
Is this Cepo CV 200 Mg/125 Mg Tablet habit forming or addictive?
No, there is no any evidence that Cepo CV 200 Mg/125 Mg Tablet is addictive.
Interaction between Food and Cepo CV 200 Mg/125 Mg Tablet
Taking Cepo CV 200 Mg/125 Mg Tablet with food does not harm your health.
Interaction between Alcohol and Cepo CV 200 Mg/125 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Cepo CV 200 Mg/125 Mg Tablet with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
